OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by OPKO Health, Inc. on March 1, 2021. The filing reports a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial performance data.
Material Changes
The material change reported is the appointment of a new director to the Board of Directors.
- Appointment: Prem A. Lachman, M.D. was appointed as a new director with immediate effect.
- Term: Dr. Lachman will serve until the Company's 2021 Annual Meeting of Stockholders and until his successor is duly elected or appointed, or upon earlier death or resignation.
- Independence: The Board determined Dr. Lachman is independent under SEC and Nasdaq rules.
- Committees: Dr. Lachman has not been named to any Board committees at this time.
Management Commentary and Compensation
Dr. Lachman brings over 35 years of experience in portfolio management, biopharmaceutical investment research, and healthcare investment banking. He is the founder and general partner of Maximus Capital, LLC and previously served at The Galleon Group and Goldman Sachs & Co.
Regarding compensation, Dr. Lachman will participate in the standard non-employee director compensation arrangements described in the Company's 2020 Proxy Statement. The Company has also entered into its standard director indemnification agreement with him.
Key Facts for Investor Verification
- Verify the independence status of Dr. Prem A. Lachman, M.D. as declared by the Board.
- Review the "Director Compensation" section of the 2020 Proxy Statement (filed April 29, 2020) to understand the specific compensation package for the new director.
- Confirm the date of the 2021 Annual Meeting of Stockholders to determine the end of Dr. Lachman's initial term.
- Check for any future filings regarding Dr. Lachman's assignment to specific Board committees.